Related Experiment Video
Updated: May 18, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Early retinol-binding protein levels are associated with growth changes in infants born to diabetic mothers
G Francescato1, M Agosti, G Bedogni
1Neonatology and NICU, Maternal and Child Department, Filippo Del Ponte Hospital, Varese, Italy.
Insights
Early retinol-binding protein (RBP) levels may predict infant growth changes. This study explored biochemical markers in infants born to mothers with gestational diabetes mellitus (GDM).
Area of Science:
- Neonatal research
- Pediatric endocrinology
- Maternal-fetal medicine
Background:
- Lack of established biochemical predictors for infant growth.
- Gestational diabetes mellitus (GDM) impacts fetal development.
- Need for early growth assessment tools.
Purpose of the Study:
- Investigate associations between early biomarkers and infant growth.
- Evaluate retinol-binding protein (RBP), docosahexaenoic acid, and insulin (I) as predictors.
- Focus on infants born to mothers with GDM.
Main Methods:
- Longitudinal study of 56 infants (GDM-I and GDM-D groups).
- Biochemical markers measured within 72 hours of birth.
- Growth assessed at 0, 1, 3, 6, and 12 months.
Main Results:
- Early RBP levels and maternal BMI associated with weight changes.
- Early RBP and insulin levels linked to length changes.
- No significant differences observed between GDM-I and GDM-D infants.
Conclusions:
- Early retinol-binding protein (RBP) levels show potential as a growth predictor.
- Further research is warranted to validate RBP's predictive role.
- Findings contribute to understanding GDM's impact on infant growth.
Background:
Biochemical predictors of infants' growth changes are not available.
Objectives:
We tested whether retinol-binding protein (RBP), docosahexaenoic acid and insulin (I) measured within 72 h from birth are associated with growth changes in infants born to mothers with gestational diabetes mellitus (GDM).
Methods:
Fifty-six children, 32 born to diabetic mothers treated with insulin (GDM-I) and 24 born to diabetic mothers treated with diet (GDM-D), were evaluated at 0, 1, 3, 6 and 12 months of life.
Results:
At multivariable regression performed using generalized estimating equations, early RBP levels and maternal body mass index were associated to average weight changes and early RBP and insulin levels to average length changes, respectively. There was no difference between GDM-I and GDM-D infants.
Conclusions:
This exploratory study suggests that early RBP levels may be a predictor of growth changes.
Related Concept Videos
Diabetic Retinopathy
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

